Digital Asset DirectSpectrumX Holdings ready for first in-human clinical trial
SpectrumX Holdings UK Ltd
Contact Details Proactive Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com
December 13, 2022 04:33 AM Eastern Standard Time
Video
Digital Asset Direct
Digital Asset DirectPoolbeg Pharma receives initial results from human challenge clinical study
Poolbeg Pharma PLC
Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com
December 12, 2022 06:59 AM Eastern Standard Time
Video
Digital Asset DirectEvgen Pharma "cash runway in pretty good shape"
Evgen Pharma PLC
Contact Details Proactive Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com
December 12, 2022 06:53 AM Eastern Standard Time
Video
Digital Asset DirectBiVictriX Therapeutics makes "fundamental step forward"
BiVictriX Therapeutics PLC
Contact Details Proactive Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com
December 12, 2022 06:36 AM Eastern Standard Time
Video
Digital Asset DirectGoodbody Health sees a "great need" for convenient clinical testing
Goodbody Health Ltd
Contact Details Proactive Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com
December 12, 2022 06:33 AM Eastern Standard Time
Video
Digital Asset DirectEmpower Clinics and Specialty Network of North America to bring services to underserved communities
Empower Clinics Inc.
Contact Details Proactive Investors Canada Proactive Studio +1 604-688-8158 na-editorial@proactiveinvestors.com Company Website https://www.proactiveinvestors.ca/
December 08, 2022 08:44 AM Pacific Standard Time
Video
Digital Asset DirectMGC Pharmaceuticals delivers its largest-ever order
MGC Pharmaceuticals Ltd
Contact Details Proactive Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com
December 08, 2022 08:46 AM Eastern Standard Time
Video
Digital Asset DirectThe Vaccine Group completes two deadly disease vaccination projects
Frontier IP Group PLC
Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com
December 07, 2022 08:24 AM Eastern Standard Time
Video
Digital Asset DirectContext Therapeutics announces bispecific antibody clinical candidate to treat CLDN6+ cancers
Context Therapeutics
Contact Details Proactive Investors USA Proactive Investors USA +1 347-449-0879 na-editorial@proactiveinvestors.com
December 06, 2022 03:40 AM Pacific Standard Time
Video